One study concluded that the drug “does not act as an agent for improving athletic performance as popular beliefs suggest.”
He added: “Thus, the consumption of cannabis before exercise should be avoided in order to maximize athletic performance.”
WADA spokesperson Jon Fitzgerald said WADA “consults with all stakeholders regarding substances or methods that maybe should be added or removed”, and added that ” Throughout this period, the United States has maintained its firmly anchored position. that WADA should keep cannabis on the List.
Mr Fitzgerald said the AMA authors “support” the 2011 scientific analysis, published in the journal Sports Medicine, which extensively examines the effects of marijuana use on athletes. One section is devoted to the drug’s potential to improve performance and draws on a handful of previous scientific studies to support this possibility.
Experts say WADA’s analysis goes beyond what previous documents have actually said.
In one example, the 2011 analysis distorts the position expressed by a scientist named Jon Wagner in his 1989 article titled “Abuse of Drugs Used to Enhance Athletic Performance”. The AMA paper claims that Dr Wagner “described cannabis as ergogenic,” that is, performance enhancing. Dr Wagner, a former assistant professor at the University of Nebraska now working in the biotech industry, disagreed.
“I didn’t write this,” Dr. Wagner said in an interview. In the article, he wrote that marijuana does not improve “vital capacity” or grip strength and that if marijuana helps at all, it would be by helping an athlete relax. In an interview, he said he got this latest idea from anecdotal conversations with tennis players.
“It’s just that,” Dr. Wagner said. “People are just talking.”
“It was like a disposable line,” he added. “I never imagined it would have an impact in the world of the Olympics.”